Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-(3-(2-amino-1-fluoroethylidene)-1-piperidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid
2. Jnj Q2
3. Jnj-q2
1. Avarofloxacin
2. Jnj-q2
3. 878592-87-1
4. Jnj-32729463-aaa
5. 070sv15rja
6. Acorafloxacin (usan)
7. Acorafloxacin [usan]
8. 7-((3e)-3-(2-amino-1-fluoroethylidene)-1-piperidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid
9. 7-[(3e)-3-(2-amino-1-fluoroethylidene)piperidin-1-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic Acid
10. 3-quinolinecarboxylic Acid, 7-[(3e)-3-(2-amino-1-fluoroethylidene)-1-piperidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-
11. Acorafloxacin [usan:inn]
12. Unii-070sv15rja
13. Jnjq2
14. Acorafloxacin [inn]
15. Avarofloxacin (former Name)
16. Avarofloxacin [who-dd]
17. Schembl2190708
18. Schembl2190721
19. Chembl1257096
20. Gtpl10753
21. Dtxsid20236667
22. Zinc34661474
23. Hy-16764
24. Cs-0012379
25. D10435
26. Q6108575
| Molecular Weight | 419.4 g/mol |
|---|---|
| Molecular Formula | C21H23F2N3O4 |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 96.1 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 782 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Acorafloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acorafloxacin, including repackagers and relabelers. The FDA regulates Acorafloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acorafloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Acorafloxacin supplier is an individual or a company that provides Acorafloxacin active pharmaceutical ingredient (API) or Acorafloxacin finished formulations upon request. The Acorafloxacin suppliers may include Acorafloxacin API manufacturers, exporters, distributors and traders.
Acorafloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acorafloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acorafloxacin GMP manufacturer or Acorafloxacin GMP API supplier for your needs.
A Acorafloxacin CoA (Certificate of Analysis) is a formal document that attests to Acorafloxacin's compliance with Acorafloxacin specifications and serves as a tool for batch-level quality control.
Acorafloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Acorafloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acorafloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Acorafloxacin EP), Acorafloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acorafloxacin USP).
LOOKING FOR A SUPPLIER?
